South San Francisco, CA, United States of America

Hongkang Xi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 10.7

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Hongkang Xi**

Introduction

Hongkang Xi, an innovative thinker based in South San Francisco, California, has made significant contributions to the field of biomedical research. With a total of four patents to his name, Xi's work primarily focuses on the development of novel therapeutic antibodies, specifically targeting interleukin-33 (IL-33) and its related disorders.

Latest Patents

Hongkang Xi's latest patents include advancements in anti-interleukin-33 antibodies and their uses. One notable invention provides a method for creating interleukin-33 antibodies, which can be utilized in the treatment of IL-33 mediated disorders. These disorders include ocular conditions such as Age-related Macular Degeneration (AMD) and geographic atrophy (GA). His innovative approach not only enhances the understanding of IL-33's role in these diseases but paves the way for potential therapeutic interventions.

Career Highlights

Currently, Hongkang Xi is associated with Genentech, Inc., a leading biotechnology company that focuses on developing medicines for serious and life-threatening diseases. His expertise in immunotherapy and antibody engineering has been instrumental in driving forward the company's research initiatives and product development.

Collaborations

Throughout his career, Xi has collaborated with notable colleagues such as Gerald R. Nakamura and Dhaya Seshasayee. These collaborations have fostered an environment of shared knowledge and innovation, contributing significantly to advancements in therapeutic technologies and potential clinical applications.

Conclusion

Hongkang Xi's work epitomizes the spirit of innovation in the field of biotechnology. His commitment to developing therapeutic solutions for complex disorders showcases the importance of research and invention in improving patient outcomes. As he continues to push the boundaries of biomedical science, Xi remains a key figure to watch in the realm of pharmaceutical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…